IP Library › Granted Patent US 10,248,758
Granted Patent B2
US 10,248,758 · App. 14/759,308 · Granted Apr 2, 2019

Self-assembling protein nanostructures

Inventors: David Baker (Seattle, WA); Neil King (Seattle, WA); Jacob Bale (Seattle, WA); William Sheffler (Seattle, WA)
Assignee: University of Washington Through its Center for Commercialization
G06F19/18C07K14/00C07K14/195G01N33/6845G06F19/12G06F19/16B82Y5/00C07K2319/735G01N2570/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,248,758
App. No.
14/759,308
Granted
Apr 2, 2019
Kind
B2
Abstract

Synthetic nanostructures, proteins that are useful, for example, in making synthetic nanostructures, and methods for designing such synthetic nanostructures are disclosed herein.

Claims (50)

1. An isolated nanostructure, comprising

(a) a plurality of first proteins that self-interact to form a first multimeric substructure comprising at least one axis of rotational symmetry; and

(b) a plurality of second proteins that self-interact to form a second multimeric substructure comprising at least one axis of rotational symmetry;

wherein multiple copies of the first multimeric substructure and the second multimeric substructure interact with each other at one or more symmetrically repeated, non-natural, non-covalent protein-protein interfaces that orient the first multimeric substructures and the second multimeric substructures such that their symmetry axes are aligned with symmetry axes of the same kind in a designated mathematical symmetry group;

wherein the first protein and the second protein comprise proteins selected from the following pairs of first and second proteins:

(a) T32-28A (SEQ ID NO: 11) and T32-28B (SEQ ID NO: 12);

(b) T33-09A (SEQ ID NO: 13) and T33-09B (SEQ ID NO: 14);

(c) T33-15A (SEQ ID NO: 15) and T33-15B (SEQ ID NO: 16);

(d) T33-21A (SEQ ID NO: 17) and T33-21B (SEQ ID NO: 18);

(e) T33-28A (SEQ ID NO: 19) and T33-28B (SEQ ID NO: 20);

(f) T32-28A (SEQ ID NO: 21) and T32-28B (SEQ ID NO: 22);

(g) T33-09A (SEQ ID NO: 23) and T33-09B (SEQ ID NO: 24);

(h) T33-15A (SEQ ID NO: 25) and T33-15B (SEQ ID NO: 26);

(i) T33-21A (SEQ ID NO: 27) and T33-21B (SEQ ID NO: 28);

(i) T33-28A (SEQ ID NO: 29) and T33-28B (SEQ ID NO: 30);

(k) T32-28A (SEQ ID NO: 31) and T32-28B (SEQ ID NO: 32);

(l) T33-09A (SEQ ID NO: 33) and T33-09B (SEQ ID NO: 34);

(m) T33-15A (SEQ ID NO: 35) and T33-15B (SEQ ID NO: 36);

(n) T33-21A (SEQ ID NO: 37) and T33-21B (SEQ ID NO: 38); and

(o) T33-28A (SEQ ID NO: 39) and T33-28B (SEQ ID NO: 40).

2. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T32-28A (SEQ ID NO: 11) and T32-28B (SEQ ID NO: 12).

3. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-09A (SEQ ID NO: 13) and T33-09B (SEQ ID NO: 14).

4. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-15A (SEQ ID NO: 15) and T33-15B (SEQ ID NO: 16).

5. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-21A (SEQ ID NO: 17) and T33-21B (SEQ ID NO: 18).

6. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-28A (SEQ ID NO: 19) and T33-28B (SEQ ID NO: 20).

7. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T32-28A (SEQ ID NO: 21) and T32-28B (SEQ ID NO: 22).

8. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-09A (SEQ ID NO: 23) and T33-09B (SEQ ID NO: 24).

9. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-15A (SEQ ID NO: 25) and T33-15B (SEQ ID NO: 26).

10. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-21A (SEQ ID NO: 27) and T33-21B (SEQ ID NO: 28).

11. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-28A (SEQ ID NO: 29) and T33-28B (SEQ ID NO: 30).

12. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T32-28A (SEQ ID NO: 31) and T32-28B (SEQ ID NO: 32).

13. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-09A (SEQ ID NO: 33) and T33-09B (SEQ ID NO: 34).

14. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-15A (SEQ ID NO: 35) and T33-15B (SEQ ID NO: 36).

15. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-21A (SEQ ID NO: 37) and T33-21B (SEQ ID NO: 38).

16. The isolated nanostructure of claim 1 , wherein the first protein and the second protein comprise T33-28A (SEQ ID NO: 39) and T33-28B (SEQ ID NO: 40).

17. An isolated nanostructure, comprising

(a) a plurality of first proteins that self-interact to form a first multimeric substructure comprising at least one axis of rotational symmetry; and

(b) a plurality of second proteins that self-interact to form a second multimeric substructure comprising at least one axis of rotational symmetry;

wherein multiple copies of the first multimeric substructure and the second multimeric substructure interact with each other at one or more symmetrically repeated, non-natural, non-covalent protein-protein interferences that orient the first multimeric substructures and the second multimeric substructures such that their symmetry axes are aligned with symmetry axes of the same kind in a designated mathematical symmetry group;

wherein the first protein and the second protein comprise proteins selected from the following pairs of first and second proteins:

(a) SEQ ID NOs: 1 and 2;

(b) SEQ ID NOs: 3 and 4;

(c) SEQ ID NOs: 5 and 6;

(d) SEQ ID NOs: 7 and 8; and

(e) SEQ ID NOs: 9 and 10.

18. The isolated nanostructure of claim 17 , wherein the first protein and the second protein comprise SEQ ID NOS: 1-2.

19. The isolated nanostructure of claim 17 , wherein the first protein and the second protein comprise SEQ ID NOS: 3-4.

20. The isolated nanostructure of claim 17 , wherein the first protein and the second protein comprise SEQ ID NOS: 5-6.

21. The isolated nanostructure of claim 17 , wherein the first protein and the second protein comprise SEQ ID NOS: 7-8.

22. The isolated nanostructure of claim 17 , wherein the first protein and the second protein comprise SEQ ID NOS: 9-10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2015
From: BAKER, DAVID; KING, NEIL; BALE, JACOB; SHEFFLER, WILLIAM
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 037190/0886 →
Continuity (2)
Provisional Application 61762194 · Feb 7, 2013
Related Publication 20150356240A1 · Dec 10, 2015